

Nelnet vs Oscar Health
Nelnet services student loans and provides education technology platforms while Oscar Health sells individual and small group health insurance through a tech-first distribution model. Both companies are trying to reduce friction in markets where complexity frustrates consumers and creates inefficiency. Nelnet vs Oscar Health shows how a mature education finance servicer generating steady cash flows compares against a health insurance disruptor still working toward sustainable underwriting profitability in a highly regulated, cost-volatile market.
Nelnet services student loans and provides education technology platforms while Oscar Health sells individual and small group health insurance through a tech-first distribution model. Both companies a...
Investment Analysis

Nelnet
NNI
Pros
- Nelnet reported strong first quarter 2025 earnings, with net income excluding derivative adjustments up 29.7% year-on-year.
- The company maintains a diversified business model across loan servicing, education technology, and financial services, supporting stable revenue streams.
- Nelnet has enhanced its capital and liquidity positions, providing flexibility for strategic investments and resilience in uncertain markets.
Considerations
- The stock is trading at a significant premium to some discounted cash flow fair value estimates, suggesting potential overvaluation risks.
- Nelnet's debt-to-equity ratio remains high, which could constrain financial flexibility if interest rates rise further.
- The company's performance is sensitive to changes in student loan policies and broader economic conditions affecting loan demand.

Oscar Health
OSCR
Pros
- Oscar Health has raised its full-year 2025 revenue outlook, indicating strong growth momentum in its core insurance business.
- The company delivered better-than-expected Q1 2025 earnings, beating consensus EPS and revenue estimates.
- Oscar Health continues to expand its customer base and market presence, supported by increasing demand for digital health solutions.
Considerations
- Oscar Health reported a significant net loss in Q2 2025, reflecting ongoing profitability challenges in the competitive health insurance sector.
- The company's share price is highly volatile, with a beta above 1.8, increasing risk for investors during market downturns.
- Oscar Health faces regulatory and legal risks, including lawsuits over Affordable Care Act rules that could impact future operations.
Buy NNI or OSCR in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


